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A B S T R A C T
Background
There are various reasons why weaning and extubation failure occur, but ineffective cough and secretion retention can play a significant
role. Cough augmentation techniques, such as lung volume recruitment or manually- and mechanically-assisted cough, are used to
prevent and manage respiratory complications associated with chronic conditions, particularly neuromuscular disease, and may improve
short- and long-term outcomes for people with acute respiratory failure.However, the role of cough augmentation to facilitate extubation
and prevent post-extubation respiratory failure is unclear.
Objectives
Our primary objective was to determine extubation success using cough augmentation techniques compared to no cough augmenta-
tion for critically-ill adults and children with acute respiratory failure admitted to a high-intensity care setting capable of managing
mechanically-ventilated people (such as an intensive care unit, specialized weaning centre, respiratory intermediate care unit, or high-
dependency unit).
Secondary objectives were to determine the effect of cough augmentation techniques on reintubation, weaning success, mechanical
ventilation and weaning duration, length of stay (high-intensity care setting and hospital), pneumonia, tracheostomy placement and
tracheostomy decannulation, and mortality (high-intensity care setting, hospital, and after hospital discharge). We evaluated harms
associated with use of cough augmentation techniques when applied via an artificial airway (or non-invasive mask once extubated/
decannulated), including haemodynamic compromise, arrhythmias, pneumothorax, haemoptysis, andmucus plugging requiring airway
change and the type of person (such as those with neuromuscular disorders or weakness and spinal cord injury) for whom these
techniques may be efficacious.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL; Issue 4, 2016), MEDLINE (OvidSP) (1946 to April
2016), Embase (OvidSP) (1980 to April 2016), CINAHL (EBSCOhost) (1982 to April 2016), and ISIWeb of Science and Conference
Proceedings. We searched the PROSPERO and Joanna Briggs Institute databases, websites of relevant professional societies, and
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conference abstracts from five professional society annual congresses (2011 to 2015). We did not impose language or other restrictions.
We performed a citation search using PubMed and examined reference lists of relevant studies and reviews. We contacted corresponding
authors for details of additional published or unpublished work. We searched for unpublished studies and ongoing trials on the
International Clinical Trials Registry Platform (apps.who.int/trialsearch) (April 2016).
Selection criteria
We included randomized and quasi-randomized controlled trials that evaluated cough augmentation compared to a control group
without this intervention. We included non-randomized studies for assessment of harms. We included studies of adults and of children
aged four weeks or older, receiving invasive mechanical ventilation in a high-intensity care setting.
Data collection and analysis
Two review authors independently screened titles and abstracts identified by our search methods. Two review authors independently
evaluated full-text versions, independently extracted data and assessed risks of bias.
Main results
We screened 2686 citations and included two trials enrolling 95 participants and one cohort study enrolling 17 participants. We assessed
one randomized controlled trial as being at unclear risk of bias, and the other at high risk of bias; we assessed the non-randomized
study as being at high risk of bias. We were unable to pool data due to the small number of studies meeting our inclusion criteria and
therefore present narrative results rather than meta-analyses. One trial of 75 participants reported that extubation success (defined as no
need for reintubation within 48 hours) was higher in the mechanical insufflation-exsufflation (MI-E) group (82.9% versus 52.5%, P <
0.05) (risk ratio (RR) 1.58, 95% confidence interval (CI) 1.13 to 2.20, very low-quality evidence). No study reported weaning success
or reintubation as distinct from extubation success. One trial reported a statistically significant reduction in mechanical ventilation
duration favouring MI-E (mean difference -6.1 days, 95% CI -8.4 to -3.8, very low-quality evidence). One trial reported mortality,
with no participant dying in either study group. Adverse events (reported by two trials) included one participant receiving the MI-
E protocol experiencing haemodynamic compromise. Nine (22.5%) of the control group compared to two (6%) MI-E participants
experienced secretion encumbrance with severe hypoxaemia requiring reintubation (RR 0.25, 95%CI 0.06 to 1.10). In the lung volume
recruitment trial, one participant experienced an elevated blood pressure for more than 30 minutes. No participant experienced new-
onset arrhythmias, heart rate increased by more than 25%, or a pneumothorax.
For outcomes assessed using GRADE, we based our downgrading decisions on unclear risk of bias, inability to assess consistency or
publication bias, and uncertainty about the estimate of effect due to the limited number of studies contributing outcome data.
Authors’ conclusions
The overall quality of evidence on the efficacy of cough augmentation techniques for critically-ill people is very low. Cough augmentation
techniques when used in mechanically-ventilated critically-ill people appear to result in few adverse events.
P L A I N L A N G U A G E S U M M A R Y
Promoting cough in critically-ill adults and children to enable removal of the breathing tube (extubation) and breathing without
the machine (weaning)
Background and importance
Critically-ill adults and children who need assistance from machines (ventilators) to help them breathe may have difficulty coughing
and clearing secretions. This can reduce their chances of successful removal of the breathing tube (extubation) and being able to breathe
without the machine. Their respiratory muscles may be weak; they may have neuromuscular disorders, spinal cord injury, or restrictive
lung disease, or be experiencing delirium, cognitive impairment or additive effects of sedation. Techniques such as building up the
volume of air in the lungs over a number of breaths (breathstacking), manually- and mechanically-assisted cough with an insufflation-
exsufflation (MI-E) device can be used to encourage people to cough. The potential for these techniques to help critically-ill adults and
children to come off and stay off the ventilator is unclear.
Review question
Do techniques that promote cough in mechanically-ventilated, critically-ill adults and children in a high-intensity care setting improve
rates of successful extubation and weaning?
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Review purpose
To look at controlled studies of techniques to promote cough in critically-ill adults and children, to see if these techniques are useful
for helping them come off and stay off the ventilator, and to determine if there are any associated harms. The complications we looked
for included decreased or increased blood pressure, irregular heart rhythm, leakage of air from the lungs to the chest cavity, coughing
up blood, and mucus plugging requiring a new breathing tube.
Review findings
We found two randomized controlled trials (95 adult participants) and one non-randomized controlled study (17 children aged at least
four weeks) conducted in Portugal, Canada, and the United States. We rated the two randomized trials as being of unclear quality and
the non-randomized study as being low quality. The largest randomized trial (75 participants) found a 83% success rate for extubation
with mechanically- and manually-assisted cough used in combination, compared with 53% in the control group (extubation success
over 1½ times more likely) (very low-quality evidence). The time spent on a ventilator was six days less in people using mechanically-
and manually-assisted cough (very low-quality evidence). No participants died in this trial.
Complications were reported by the two randomized trials. One person receiving mechanically-assisted cough experienced a prolonged
drop in blood pressure; another person receiving breathstacking and suctioning in addition to manually-assisted cough experienced
a prolonged rise in blood pressure. In one trial, following removal of the breathing tube, more people in the group not receiving
mechanically-assisted cough experienced secretion retention, a drop in oxygen levels, and needed the breathing tube to be reinserted
(nine people compared with two, very low-quality evidence).
The non-randomized study reported that the breathing tube could be removed in all of the six children in the group receiving
interventions to assist with coughing. In this non-randomized study, death was only reported for children receiving a cough-promoting
technique. One child died, but this was not thought to be related to the cough technique. This study did not report adverse events
associated with assisted coughing. No included study evaluated a single cough-promoting technique in isolation. The two randomized
trials combined manually-assisted cough with either mechanical assistance (MI-E) or breathstacking, and the non-randomized study
used all three methods.
Conclusions
Very low-quality evidence from single trial findings suggests that cough-promoting techniques might increase successful removal of the
breathing tube and decrease the time spent on mechanical ventilation, while not causing harm. The limited participant numbers made
it difficult to determine the likelihood of harms.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Cough augmentation techniques compared with no cough augmentation techniques for critically- ill, mechanically-ventilated adults and children
Patient or population: crit ically-ill mechanically-vent ilated adults and children requiring extubat ion f rom mechanical vent ilat ion
Settings: High acuity sett ing including ICUs, weaning centres, respiratory intermediate care units, and high-dependency units in Europe and North America
Intervention: Cough augmentat ion techniques including lung volume recruitment, manually-assisted cough and mechanical insuf f lat ion-exsuf f lat ion
Comparison: No cough augmentat ion
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
No cough augmenta-
tion
Cough augmentation
Extubat ion successa 87% 83% RR 1.58 (1.13 to 2.20) 75 part icipants
1 trial
⊕©©©
very low1
Durat ion of mechanical
vent ilat ionb
4 days 11.7 days Mean dif ference -6.1
days (-8.4 to -3.8)
75 part icipants
1 trial
⊕©©©
very low1
ICU mortalitya 28% 0% Not calculable, as no
event rates in the 1 trial
report ing data on this
outcome
75 part icipants
1 trial
⊕©©©
very low1
Adverse events
1. Hypotensionc
2. Hypertensiond
3. Secret ion encum-
brance result ing in se-
vere hypoxaemia re-
quiring reintubat ionc
12%
6.5%
9%
3%
10%
6%
RR 3.4 (0.1 to 81.3)
RR 3.0 (0.1 to 65.9)
RR 0.25 (0.1 to 1.1)
75 part icipants
1 trial
20 part icipants
1 trial
75 part icipants
1 trial
⊕©©©
very low2
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* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: Risk Ratio
aAssumed risk is derived f rom a large internat ional cohort study of mechanical vent ilat ion and weaning by Esteban 2013 and refers to the rate of reintubat ion reported in this
study
bAssumed risk is derived f rom a large internat ional cohort study of mechanical vent ilat ion and weaning by Esteban 2008.
cAssumed risk is derived f rom adverse events (hypotension and hypoxaemia) reported in a systematic review of recruitment manoeuvres in people with acute lung injury (Fan
2008).
dAssumed risk is derived f rom rates of hypertension noted during 6691 episodes of endotracheal suct ioning (Evans 2014).
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1We based our downgrading decisions f rom high to very low on unclear risk of bias, inability to assess consistency or
publicat ion bias, and uncertainty about the est imate of ef fect due to the lim ited number of studies contribut ing outcome
data.
2We based our downgrading decisions f rom high to very low on unclear risk of bias, inability to assess consistency or
publicat ion bias, imprecision due to wide conf idence intervals, and uncertainty about the est imate of ef fect due to the lim ited
number of studies contribut ing outcome data.
We have not included reintubat ion or weaning success in the ’Summary of f indings’ table as no studies reported these
outcomes.
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B A C K G R O U N D
Description of the condition
Critically-ill people receiving mechanical ventilation, via endotra-
cheal intubation or tracheostomy, may experience impaired air-
way clearance during intubation and once extubated due to in-
effective cough, respiratory muscle weakness, or paralysis associ-
ated with intensive care unit-acquired weakness (ICUAW), neuro-
muscular disorders, spinal cord injury, and restrictive lung disease
(Gonçalves 2012; Salam 2004; Smina 2003). ICUAW is a com-
mon complication of critical illness, affecting limb and respiratory
muscles, and is associated with weaning failure (Hermans 2014).
Critically-ill people with pre-existing neuromuscular disease have
ineffective peak cough flows, resulting in an inability to cough
(Bach 2010). Additional reasons for ineffective cough include the
cumulative effects of sedation and lack of patient co-operation
or effort (Smina 2003) due to delirium or cognitive impairment,
both of which are prevalent in the critically-ill population (Ouimet
2007; Pandharipande 2013). Moreover, effective cough requires
closure of the glottis, which is prevented during endotracheal in-
tubation, or by glottic muscle weakness (Smina 2003). Ineffective
cough leads to secretion pooling, atelectasis and respiratory tract
infection, which may cause weaning failure and the need for rein-
tubation (Gonçalves 2012; Salam 2004; Smina 2003). Suctioning
of the trachea via the endotracheal tube, a standard airway inter-
vention in the intensive care unit (ICU), may also impair mucocil-
iary function, and is ineffective for clearing the peripheral airways
(Nakagawa 2005), further contributing to secretion pooling.
Description of the intervention
Cough augmentation techniques comprise lung volume recruit-
ment, (also termed airstacking or breathstacking), manually-as-
sisted cough, and mechanically-assisted cough using a mechanical
insufflation-exsufflation (MI-E) device. During lung volume re-
cruitment, the person inhales a volume of gas via the ventilator,
or self-inflating resuscitation bag adapted with a one-way valve
to facilitate gas holding. The person retains the inhaled volume
by closing the glottis, inhales another volume of gas and then
again closes the glottis; this process is repeated until maximum
insufflation capacity is reached (Toussaint 2009). Lung volume
recruitment can be performed in isolation or in combination with
manually-assisted cough. Manually-assisted cough consists of a
cough timed with an abdominal thrust or lateral costal compres-
sion once maximal air-stacking is achieved and timed to glottic
opening (Bach 2012). MI-E devices such as the CoughAssist™
(Philips Respironics Corp, Millersville, PA) or the NIPPY Clear-
way (B&D Electromedical, Stratford-Upon-Avon, Warwickshire)
alternate the delivery of positive (inflation) and negative pressures
(rapid deflation) delivered to the person via an oronasal interface,
mouthpiece, or endotracheal or tracheostomy tube (Bach 2013).
MI-E comprises a pressure-targeted lung insufflation followed by
vacuum exsufflation, enabling lung emptying and increasing peak
cough flow. Alternation of pressure may be manually or automat-
ically cycled. Pressures of 40 mmHg (insufflation) to -40 mmHg
(exsufflation) (54 cmH2O) are usually most effective and best
tolerated by the person (Bach 2014). In non-critically-ill people,
few complications associated with barotrauma have been reported,
most likely due to use of pressures that are much lower than phys-
iological cough pressures and the short duration of application
(Gómez-Merino 2002). Due to pressure drop-off and reduced
peak expiratory flows, when applying MI-E via an endotracheal or
tracheostomy tube, the cuff should remain inflated and pressures
of 38 mmHg to 51 mmHg (50 cm H2O to 70 cm H2O) can
be used, depending on the person’s tolerance (Bach 2014; Guérin
2011).The duration of insufflation and exsufflation should enable
maximum chest expansion and rapid lung emptying, with two to
four seconds used for adults (Bach 2010) and shorter durations
for children (Chen 2014). Treatments usually comprise three to
five insufflation-exsufflation cycles followed by a short period of
rest to avoid hyperventilation (Bach 2012). Treatments can be re-
peated until no further secretions are expectorated. MI-E can be
performed in isolation or in combination with manually-assisted
cough.
How the intervention might work
The increased lung volumes generated via lung volume recruit-
ment increase elastic recoil, thereby increasing peak cough flow
and promoting sputum expectoration (Kang 2000). Manually-as-
sisted cough further enhances peak cough flow, particularly for
people with weak expiratory muscles (Kirby 1966).MI-E has been
shown to produce a higher peak cough flow when compared with
manual techniques (Bach 1993). Additionally, routine suctioning
does not reach the left main-stem bronchus approximately 90% of
the time (Fishburn 1990), whereas MI-E provides the same exsuf-
flation flows in left and right airways, enabling more effective se-
cretion clearance (Garstang 2000). Many primarily observational
studies over the last two decades suggest that cough augmentation
techniques are safe and efficacious in managing exacerbation of
respiratory failure due to infection in people with neuromuscular
disease or spinal cord injury in the community or a long-term care
setting (Bach 1993; Kang 2000; Kirby 1966).
Why it is important to do this review
There are various reasons why weaning and extubation failure oc-
cur, but ineffective cough and secretion retention can play a sig-
nificant role (Perren 2013). Cough augmentation techniques have
been used extensively to prevent andmanage respiratory complica-
tions associated with chronic conditions, particularly neuromus-
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cular disease, and may improve short- and long-term outcomes
for hospitalized people experiencing acute respiratory failure. At
present, the role of cough augmentation is unclear for critically-ill
people with acute respiratory failure requiring intubation and for
management of post-extubation respiratory failure.
Serious physiological sequelae are associated with mechanical ven-
tilation, necessitating efficient processes to safely prevent, reduce,
and remove invasive ventilator support. Assessment of readiness
for removal is generally undertaken using a spontaneous breath-
ing trial. Approximately 30% of people will fail this sponta-
neous breathing trial and present a greater weaning challenge
(Scheinhorn 2001), experience additional complications related to
prolongedmechanical ventilation, andpresenting a significant cost
burden to the healthcare system (Carson2006; Iregui 2002). These
people commonly experience secretion accumulation due to inef-
fective cough and altered mucociliary clearance, contributing to
weaning failure (Gonçalves 2012; Salam 2004; Smina 2003). For
them, cough augmentation techniquesmay promote weaning suc-
cess and prevent reintubation and tracheostomy (Bach 2004; Bach
2010; Chatwin 2003; Gonçalves 2012; Sancho 2003). Prevention
of extubation failure is important, as it is associated with increased
duration of mechanical ventilation, ICU and hospital length of
stay, nosocomial pneumonia, and mortality (Gowardman 2006;
Savi 2012).
O B J E C T I V E S
Our primary objective was to determine extubation success using
cough augmentation techniques compared to no cough augmen-
tation for critically-ill adults and children with acute respiratory
failure admitted to a high-intensity care setting capable of caring
for mechanically-ventilated people (such as an intensive care unit,
specialized weaning centre, respiratory intermediate care unit, or
high-dependency unit).
Secondary objectives were to determine the following:
1. The effect of cough augmentation techniques on reintubation;
weaning success; mechanical ventilation and weaning duration;
length of stay (high-intensity care setting and hospital); pneumo-
nia; tracheostomy placement and tracheostomy decannulation;
and mortality (high-intensity care setting, hospital, and after hos-
pital discharge).
2. The harms associated with use of cough augmentation tech-
niques when applied via an artificial airway (or non-invasive mask
once extubated/decannulated), including haemodynamic com-
promise, arrhythmias, pneumothorax, haemoptysis, and mucus
plugging requiring change airway change.
3. The type of person (such as those with neuromuscular disorders
or weakness and spinal cord injury) for whom these techniques
may be efficacious.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomized and quasi-randomized controlled trials
that evaluated cough augmentation techniques (lung volume re-
cruitment, manually-assisted cough and mechanical insufflation-
exsufflation (MI-E)) compared to a control group without this
intervention. We excluded randomized cross-over studies* as this
design does not allowdetermination of the efficacy of the interven-
tion on clinical outcomes such as weaning success. We included
non-randomized studies with a non-exposed control group* (non-
randomized controlled trials, prospective cohort studies, retro-
spective cohort studies and case-control studies), to assess harms
associated with cough augmentation techniques.
(* See Differences between protocol and review)
Types of participants
We included studies of adults and of children aged four weeks
or more, receiving invasive mechanical ventilation, and admitted
to a high-intensity care setting such as an ICU, specialized wean-
ing centre, respiratory intermediate care unit or high-dependency
unit. We included all high-intensity care setting patient popula-
tions, including those admitted for medical, surgical and trauma
diagnoses.
We excluded studies of cough augmentation techniques adminis-
tered in the home, community, or long-term care settings.
Types of interventions
Cough augmentation techniques included in this systematic re-
view comprised lung volume recruitment, also termed airstacking
or breathstacking as described above,manually-assisted cough, and
mechanically-assisted cough using a MI-E device. Lung volume
recruitment and MI-E may be used in isolation or in combina-
tion with manually-assisted cough. We included studies of cough
augmentation techniques used before or after extubation.
Types of outcome measures
Primary outcomes
Our primary outcome was extubation success. Extubation success
may be variably defined by study authors (Boles 2007); however,
we defined it as no further requirement for invasive mechanical
ventilation for aminimumof 24hours. As non-invasive ventilation
may be used as a strategy to facilitate extubation (Bach 2010) in
individuals with reduced ventilatory capacity, we did not consider
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its use within the 24 hours following extubation to constitute
extubation failure.
Secondary outcomes
Secondary outcomes included:
1. reintubation;
2. weaning success, defined as no further requirement for
invasive or non-invasive ventilation for a minimum of 24 hours;
3. duration of mechanical ventilation and weaning*;
4. rates of tracheostomy placement and tracheostomy
decannulation*;
5. length of stay*;
6. mortality; and
7. harm.
Potential harms included haemodynamic compromise (as defined
by study authors), arrhythmias, pneumothorax, haemoptysis, and
mucus plugging requiring change of the endotracheal or tra-
cheostomy tube associated with cough augmentation techniques.
(* See Differences between protocol and review)
Search methods for identification of studies
Electronic searches
Two review authors (LRandDM) searched indexed literature from
database inception to April 2016. Electronic databases searched
included MEDLINE (OvidSP) (1946 to April 2016), Embase
(OvidSP) (1980 to April 2016), CINAHL (EBSCOhost) (1982 to
April 2016), and ISIWeb of Science and Conference Proceedings.
We searched the Cochrane Library (Issue 4, 2016) which includes
the Cochrane Central Register of Controlled Trials (CENTRAL),
the Cochrane Database of Systematic Reviews (CDSR), Database
of Abstracts of Reviews of Effects (DARE), the Health Technol-
ogy Assessment Database (HTA Database) and the NHS Eco-
nomic Evaluation Database (NHS EED). Other systematic review
databases that we searched included PROSPERO and the Joanna
Briggs Institute. We refined the search strategies with the research
team, and had them peer-reviewed according to the PRESS guide-
lines (McGowan 2010) before formally executing them.We devel-
oped our search for MEDLINE and adapted the strategy to other
databases. (See Appendix 1 for the search strategies). Where ap-
plicable, we removed animal-only studies and opinion pieces (e.g.
editorials, letters). We did not impose language or other restric-
tions. As we included non-randomized studies, we did not apply
a filter for randomized controlled trials.
Searching other resources
We searched websites of relevant professional societies and hand-
searched conference abstracts from annual congresses from the
previous five years (2011 to 2015) of the Society of Critical Care
Medicine, American and Canadian Thoracic Societies, European
Society of Intensive CareMedicine, and International Symposium
on Intensive Care and EmergencyMedicine. We selected this five-
year time frame as it enabled identification of studies that may not
be published in full text. We performed a citation search using
PubMed. We examined reference lists of relevant studies and re-
views and contacted corresponding authors of included studies for
details of additional published or unpublished work. We searched
for unpublished studies and ongoing trials on the International
Clinical Trials Registry Platform (apps.who.int/trialsearch) (April
2016).
Data collection and analysis
Selection of studies
Two review authors (LR and DM) independently screened titles
and abstracts of electronic and manual search results against eligi-
bility criteria (Appendix 2) (Stage 1). We retrieved and examined
full-text publications of all potentially relevant articles for eligibil-
ity (Stage 2). We resolved any disagreements though discussion,
and sought an additional opinion from an independent arbiter
(NA) to reach consensus. We used the Cochrane checklist for as-
sessment of non-randomized studies to categorize study design
(Higgins 2011). We have noted the details and reasons for study
exclusion in the Characteristics of excluded studies table.
Data extraction and management
Two review authors (DL and LR) independently extracted data
from selected studies on key components, including features
of study characteristics, study design, participant characteristics,
study outcomes, complications, and adverse events, using a modi-
fied version of the Cochrane Anaesthesia, Critical and Emergency
(ACE) Care Group data extraction form (Appendix 3), iteratively
refined based on piloting of the form. For non-randomized studies
where available we extracted data on confounding factors, meth-
ods used to control confounding, and multiple effects estimates.
We referred to a third author (NA) as required to check extraction,
confirm decisions and resolve disagreement.
Assessment of risk of bias in included studies
DL and LR independently critically appraised included papers
for quality. We assessed study quality of randomized controlled
trials using the domain-based evaluation process recommended by
Cochrane (Higgins 2011). These domains include:
1. random sequence generation;
2. allocation concealment;
3. blinding;
4. incomplete outcome data;
5. selective reporting; and
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6. other bias.
For each domain, we assigned a judgement of the risk of bias as
’high risk of bias’, ‘low risk of bias’, or ‘unclear risk of bias’ (Higgins
2011). We contacted the corresponding author of studies for clar-
ification when insufficient detail was reported to assess the risk
of bias. A priori, we anticipated that no eligible trials would be
blinded to the use of cough augmentation techniques and that
non-blinding of personnel and participants would not necessarily
be considered high risk of bias when considering objective out-
comes. Once we achieved consensus on the quality assessment of
the six domains for eligible studies, we assigned them to the fol-
lowing categories.
1. Low risk of bias: describes studies for which all domains are
scored as ‘low risk of bias’
2. High risk of bias: one or more domains scored as ’high risk
of bias’*
3. Unclear risk of bias: one or more domains scored as
’unclear’ and no domains scored as ’high’*
(* See Differences between protocol and review)
For non-randomized studies (as in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011)), we generated
an a priori list of potential confounding factors, identified con-
founders considered and omitted, assessed balance between com-
parator groups, and identifiedhow selectionbiaswasmanaged. For
quality assessment of non-randomized studies we used the Scot-
tish Intercollegiate Guidelines Network (SIGN) checklists (SIGN
2014) (Appendix 4) for cohort and case-control studies, as rec-
ommended by the Quality Assessment Tools Project Report (Bai
2012). We constructed a ‘Risk of bias’ table in Review Manager
5 (RevMan 2014) to present the results. We planned to use the
assessment of risk of bias to perform sensitivity analyses based on
methodological quality, but we identified too few studies.
Measures of treatment effect
We express findings for binary outcomes in terms of risk ratios
(RRs) with 95% confidence intervals (CIs), and continuous out-
comes in terms of mean differences (MDs) and associated 95%
CIs. For observational studies we planned to report unadjusted
and adjusted effect sizes (odds ratios (ORs) for dichotomous out-
comes and MDs (or regression coefficients) for continuous out-
comes), but these data were unavailable.
Unit of analysis issues
We used individual study participants as the unit of analysis. We
anticipated that all included trials would be of a parallel-group
design and therefore did not expect to make adjustments for clus-
tering. If we identified multi-arm studies, we planned to combine
groups to create a single pair-wise comparison, as recommended
by the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011). If combining groups was not possible or feasible,
we planned to select only one treatment and control group from
each study.
Dealing with missing data
We contacted study authors to request additional information or
missing data.We sent amaximumof three emails to corresponding
authors. We had planned to exclude participants withmissing data
when calculating the risk ratio of a trial (complete-case analysis) for
dichotomous outcome data, but found too few studies to perform
these analyses.
Assessment of heterogeneity
We found too few studies to evaluate clinical and methodological
heterogeneity using forest plots of trial-level effects, and the I2
statistic (Higgins 2011), or using qualitative assessment of clinical
heterogeneity by examining potential sources, such as the type of
cough augmentation strategy in each trial and the type of partici-
pants enrolled.
Assessment of reporting biases
We planned to construct a funnel plot of the treatment effect
for the primary outcome against trial precision (standard error).
However, we did not find enough studies to create a funnel plot
or to formally test for asymmetry (Egger 1997; Peters 2006).
Data synthesis
We summarized search results in a PRISMA study flow diagram
(Moher 2009). We summarized study characteristics using fre-
quencies and percentages for categorical variables and means and
standard deviations or medians and interquartile ranges for con-
tinuous variables, depending on data distribution. We planned
separate analyses of randomized and observational studies, but we
identified too few studies to perform meta-analyses and therefore
completed only a descriptive qualitative synthesis. If we find ad-
ditional trials when we update the review, we will calculate pooled
RRs with 95% CIs using a random-effects model for binary out-
comes, allowing for adjustments that incorporate variation both
within and between studies (DeMets 1987). For continuous vari-
ables we will calculate a pooled difference of means with 95%
CIs using a random-effects model. We will consider a two-sided P
value < 0.05 to be significant. We planned to log-transform con-
tinuous skewed data, but did not perform this analysis as only one
study reported each of our continuous outcomes of interest.
For assessment of harms we planned to create a binary variable
(harm present: yes/no) and to categorize studies accordingly. We
planned to use the Peto odds ratio (Yusuf 1985) if harm outcomes
were rare and treatment groups were well-balanced, but identified
too few studies to perform this analysis.
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Subgroup analysis and investigation of heterogeneity
We did not identify enough studies to perform subgroup analyses
of adult versus paediatric populations, the cough augmentation
technique used, study location (ICU versus specialized weaning or
other acute-care location), and study population (mixed; neuro-
muscular disease, weakness or spinal cord injury; and single-lung
ventilation).
Sensitivity analysis
Wedid not identify enough studies to conduct a sensitivity analysis
for the primary outcome, excluding trials with a high risk of bias.
’Summary of findings’ table and GRADE
We used the GRADE approach (Guyatt 2008) to assess the ev-
idence quality associated with our specific outcomes (extubation
success; reintubation; weaning success, duration of mechanical
ventilation; mortality and harms (adverse events)) and constructed
a ’Summary of findings’ table using RevMan 2014. The GRADE
approach appraises the quality of a body of evidence based on the
extent to which one can be confident that an estimate of effect
or association reflects the item being assessed. The quality of a
body of evidence takes into consideration within-study risk of bias
(methodological quality), the directness of the evidence, hetero-
geneity of the data, precision of effect estimates, and risk of pub-
lication bias.
R E S U L T S
Description of studies
We identified two eligible randomized controlled trials (Crowe
2006;Gonçalves 2012), and one non-randomized study (Niranjan
1998), with intervention arms that comprised MI-E delivered in
combination with manually-assisted cough, or lung volume re-
cruitment in combinationwithmanually-assisted cough. The con-
trol groups of included studies comprised usual care, including
standard respiratory physiotherapy.
Results of the search
Our search of electronic sources described above identified 2686
citations: 2640 from electronic databases and 46 from trial reg-
istration and systematic review databases. Authors of studies in-
cluded in the review or content experts provided no additional
citations.
After checking the citation titles and abstracts retrieved from the
electronic databases, we retrieved 18 articles to review in full text.
We excluded 15 other studies as they did not meet our inclusion
criteria (see Figure 1).
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Figure 1. Study flow diagram.
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Included studies
We included two randomized controlled trials and one cohort
study, covering 112 participants in all (see Characteristics of
included studies). Study sample sizes ranged from 17 to 75. Stud-
ies were conducted in Canada (Crowe 2006), Portugal (Gonçalves
2012), and the United States (Niranjan 1998).
Study participants
The two randomized controlled trials recruited mechanically-ven-
tilated adults experiencing acute respiratory failure of mixed aeti-
ology admitted to an ICU (Gonçalves 2012; Crowe 2006). The
cohort study recruited children with neuromuscular ventilatory
failure admitted to a paediatric ICU, unable to sustain ventilator-
free breathing (Niranjan 1998).
Study interventions
We included one trial (Gonçalves 2012) of MI-E combined with
manually-assisted cough begun before extubation and after suc-
cessfully passing a spontaneous breathing trial. Eight cycles of MI-
E were administered using inspiratory and expiratory pressures of
40 cm H2O in each treatment. Participants received three daily
treatments for the 48 hours after extubation. The second included
trial (Crowe 2006) evaluated lung volume recruitment (breath-
stacking) using a resuscitation bag equipped with a one-way valve
to manually inflate to maximal insufflation capacity. Lung volume
recruitment consisted of three stacked breaths to achieve 40 cm
H2O by the third breath, followed by a 10-second breath hold.
At the end of the 10 seconds, the participant was disconnected
from the lung volume recruitment bag and a manually-assisted
cough was performed. Each session comprised four cycles of three
stacked breaths (12 stacked breaths in total), repeated twice daily
until extubated, 72 hours after randomization, or six treatment ses-
sions. The included cohort study (Niranjan 1998) used a protocol
involving breathstacking to maximum inspiratory capacity when-
ever the participant’s SaO2 dropped below 95%. Breathstacking
was followed by either manually-assisted cough or MI-E using in-
spiratory and expiratory pressures of 35 to 45 cm H2O. This pro-
cedure was repeated until sputum was expectorated and the SaO2
returned to baseline.
Excluded studies
We excluded 15 studies (Avena 2008; Bach 1996; Bach 2010;
Bach 2015; Beuret 2014; Chen 2014; Duff 2007; Jeong 2015;
Ntoumenopulos 2014; Porto 2014;Torres-Castro 2014;Toussaint
2003; Velasco Arnaiz 2011; Vianello 2005; Vianello 2011). (see
Characteristics of excluded studies). Six were non-randomized
studies without a control group (Avena 2008; Bach 1996; Bach
2010; Bach 2015; Ntoumenopulos 2014; Velasco Arnaiz 2011).
Four studies recruited participants who were not using invasive
ventilatory support at study start or actively excluded ventilated
people; cough augmentation techniques were used to improve
lung function and to prevent intubation as opposed to facilitating
weaning and preventing reintubation (Chen 2014; Jeong 2015;
Torres-Castro 2014; Vianello 2005). Two studies involved an in-
tervention that did not comprise a cough augmentation technique
(Beuret 2014; Duff 2007), two studies used a cross-over random-
ized controlled design (Porto 2014; Toussaint 2003), and one
study used manually-assisted cough in the control arm (Vianello
2011).
Awaiting classification
There are no studies awaiting classification.
Ongoing studies
A search of the trial registration database found no ongoing studies
that met our inclusion criteria.
Risk of bias in included studies
We assessed risks of bias for the two included randomized con-
trolled trials, using Cochrane’s domain-based ’Risk of bias’ tool
(Higgins 2011), and the single cohort study using the appropri-
ate SIGN checklist (SIGN 2014). We provide our judgement of
classification of bias for the two randomized controlled trials in
Characteristics of included studies section, with a summary pre-
sented in Figure 2.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Both trials (Crowe 2006; Gonçalves 2012) used a computer-gen-
erated table for random sequence generation. Both studies used
adequate measures for allocation concealment.
Blinding
As anticipated, neither trial blinded study personnel or partici-
pants to the intervention. Lack of blinding may have influenced
clinician decision-making on if and when to reintubate a partic-
ipant reporting extubation success and the need for reintubation
(Gonçalves 2012), resulting in unclear performance bias. InCrowe
2006 the radiologist assessing the chest radiograph and applying
the atelectasis score (primary outcome) was blinded to allocation.
In Gonçalves 2012, we were unable to determine if assessors were
blinded and we therefore rated risk of detection bias as unclear.
Incomplete outcome data
We did not detect evidence of attrition bias in the two randomized
controlled trials.
Selective reporting
We identified a trial protocol registered by Gonçalves 2012, but
this protocol was registered after study completion and we there-
fore rated the risk of reporting bias as unclear. We did not locate
a trial registration by Crowe 2006, but the outcomes reported
matched the primary and secondary objectives described, and we
considered them appropriate for trials of this intervention
Other potential sources of bias
In Gonçalves 2012, two authors received funding from Philips
Respironics Inc., who manufactured the MI-E device used in the
trial. We were unable to ascertain if this company had any role in
providing funding or support for the trial and therefore assessed
the risk of bias fromother potential sources as unclear. Crowe 2006
was forced to stop early, reaching only half of the target sample
size due to failure to recruit participants. We therefore rated the
risk of bias from other potential sources as unclear
Risk of bias in the included non-randomized study
Using the appropriate SIGN checklist (SIGN 2014), we assessed
the single cohort study (Niranjan 1998) as follows:
Selection of participants
It was unclear if participants were taken from comparable popu-
lations or whether selection criteria were differentially applied.
Assessment
We found outcome definitions to be unclear. There was no evi-
dence that outcome assessment was blinded to exposure, or recog-
nition that knowledge of exposure status could have influenced
outcome assessment. However, end points were mostly objective
in nature and likely not susceptible to bias.
Confounding
We found no evidence that the main potential confounders were
identified and taken into account in the design and analysis of
the study. Overall we rated the risk of bias as high, with no clear
evidence of an association between exposure and outcome.
Effects of interventions
See: Summary of findings for themain comparison Summary of
findings for themain comparison: cough augmentation techniques
versus no cough augmentation technique
See (Summary of findings for the main comparison)
Primary outcome: extubation success
Data on this outcome were available in one trial of 75 partici-
pants (Gonçalves 2012) and one non-randomized study (Niranjan
1998) of 17 children. Gonçalves 2012 defined extubation success
as no requirement for reintubation within 48 hours of extubation.
Participants could receive non-invasive ventilation during this 48-
hour period and still be classified as an extubation success.Niranjan
1998 defined extubation success as no requirement for reintuba-
tion before ICU discharge. Children were extubated to continu-
ous non-invasive intermittent positive pressure ventilation and use
of non-invasive ventilation did not preclude definition of extu-
bation success. Gonçalves 2012 reported a statistically significant
difference in extubation success rates favouring theMI-E protocol
(82.9% versus 52.5%, P < 0.05) (risk ratio (RR) 1.58, 95% confi-
dence interval (CI) 1.13 to 2.20, very low-quality evidence) (Table
1). The non-randomized study (Niranjan 1998) reported that all
of the six intubated children meeting the inclusion criteria were
successfully extubated. However, all children in the control group
received a tracheostomy, as this was the standard care procedure
at that time, making comparison problematic. For this reason, we
retained only the trial of 75 participants (Gonçalves 2012) for
rating the quality of evidence for this outcome. We downgraded
the evidence rating from high quality to very low quality, due to
unclear risk of bias, inability to assess consistency or publication
bias, and uncertainty about the estimate of effect due to the lim-
ited number of studies contributing outcome data.
Secondary outcomes
No study reported reintubation rates other than those used to de-
fine extubation success, or reportedweaning success as an outcome
distinct from extubation success. One study (Gonçalves 2012) re-
ported the duration of mechanical ventilation with a statistically
significant reduction favouring the MI-E protocol (mean differ-
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ence (MD) -6.1 days, 95% CI -8.4 to -3.8, very low-quality of ev-
idence). No study reported the duration of weaning. Two studies
reported on ICU length of stay (Gonçalves 2012; Niranjan 1998).
Gonçalves 2012 reported a statistically non-significant mean dif-
ference in ICU length of stay (-2.4 days, 95%CI -6.85 to 2.05, very
low-quality evidence). Niranjan 1998 reported a statistically non-
significant mean difference in ICU length of stay (-3.5 days, 95%
CI -10.84 to 3.84) (Table 1), but this analysis included four chil-
dren in the intervention arm who received cough augmentation
techniques to prevent intubation, as opposed to the six children
that received cough augmentation techniques to prevent reintuba-
tion. Only one trial (Gonçalves 2012) reported on ICU mortality
in the 48 hours following extubation, with no participant in either
group dying within this time frame (very low-quality evidence).
Niranjan 1998 reported mortality in the follow-up period after
hospital discharge but only for those receiving the intervention,
making comparison problematic. Of the six children that were
ventilated at study entry, one died six months after ICU discharge
(Table 1). We downgraded the evidence rating from high quality
to very low quality for these secondary outcomes, for the same
reasons as listed for the primary outcome. No studies reported on
pneumonia, tracheostomy, or tracheostomy decannulation.
Adverse events
Two studies (Crowe 2006; Gonçalves 2012) reported on adverse
events (Table 2). Crowe 2006 reported that one participant in
the breathstacking protocol experienced an episode of coughing
during suctioning, with the participant’s blood pressure remaining
elevated to a maximum of 190 mmHg for more than 30 minutes.
No participant in either study group experienced new-onset ar-
rhythmias, more than a 25% increase in heart rate, or developed
a pneumothorax. Gonçalves 2012 reported that one participant
receiving the MI-E protocol compared to no participants in the
control group experienced haemodynamic compromise, defined
as systolic blood pressure lower than 90 mmHg for more than
30 minutes. Nine (22.5%) of the control group compared to two
(6%) participants receiving the MI-E protocol experienced secre-
tion encumbrance associated with severe hypoxaemia, warranting
reintubation (RR 0.25, 95% CI 0.06 to 1.10, very low-quality ev-
idence). Niranjan 1998 did not report adverse events associated
with the study intervention.
Type of participants
Due to the small number of included studies with most outcomes
of interest only reported in a single study, we are unable to de-
termine the type of patients for whom these techniques are most
likely to be efficacious.
D I S C U S S I O N
Summary of main results
Because we only found three small studies, including two random-
ized controlled trials, with reporting of most outcomes of inter-
est in a single study, and very low quality of evidence, we have
not found sufficient evidence to suggest that cough augmentation
techniques influence extubation andweaning success or reduce the
time spent on a ventilator. Adverse events associated with cough
augmentation techniques and deaths were uncommon, but lim-
ited study and participant numbers make it difficult to determine
the likelihood of harms associated with the treatment.
Overall completeness and applicability of
evidence
Both randomized controlled trials (Crowe 2006; Gonçalves 2012)
included a heterogeneous population of adults, meaning the study
findings may be applicable to the patient populations found
in most mixed ICU environments. The non-randomized study
(Niranjan 1998) included children with known neuromuscular
disease, and is of limited relevance because of the lack of report-
ing of some outcomes for the historical controls. The largest trial
(Gonçalves 2012) excluded participants with neuromuscular dis-
ease, as these patients who are ventilator-dependent are unable to
produce effective cough flows without assistance. Two large case
series that we excluded due to the absence of a control group re-
port extubation success rates in 157 (Bach 2010) and 98 (Bach
2015) participants with neuromuscular disease or weakness and
vital capacities less than 20% of normal. In these case series, cough
augmentation techniques (lung volume recruitment, manually-
assisted cough, and MI-E) were used before and after extubation
to continuous non-invasive ventilation using assist/volume con-
trol mode. Extubation success rates, defined as no requirement for
reintubation during hospitalization, were 95% and 91% respec-
tively. Therefore, although randomized controlled trials are lack-
ing in the acutely- and critically-ill neuromuscular patient popu-
lation, some evidence suggests these techniques are efficacious.
We can draw no conclusions as to which cough augmentation
technique may demonstrate benefit or result in harm, as no in-
cluded study evaluated a single cough augmentation technique
in isolation. The two randomized trials (Crowe 2006; Gonçalves
2012) both combined manually-assisted cough with either MI-
E or lung volume recruitment, while the non-randomized study
used all three methods.Neither can we draw any conclusions on
the most efficacious method of using the individual cough aug-
mentation techniques. For example, both MI-E and lung volume
recruitment treatments can be administered at variable intervals
throughout a 24-hour period. These treatments can comprise a
variable number of cycles, and MI-E can be delivered at a range
of pressures.
Quality of the evidence
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Overall, the quality of the evidence for our outcomes of interest
was very low, due to the methodological limitations of the in-
cluded studies and lack of data, with only one trial contributing
to our outcomes of interest. Evidence quality from the larger ran-
domized controlled trial (Gonçalves 2012) was unclear, because
of a lack of blinding of clinical staff due to the nature of the in-
tervention and the potential for performance bias, particularly as
reintubation was at the discretion of the attending physician who
was not blinded to study allocation. There was also unclear risk for
selective reporting due to publication of the trial registration after
completion of participant enrolment, and an unclear relationship
of the device manufacturer to the study. Due to early discontin-
uation of the smaller randomized controlled trial (Crowe 2006),
we considered risk of other bias as unclear. The non-randomized
study (Niranjan 1998) had low strength of evidence, as we were
unable to tell if participants in the intervention and non-inter-
vention groups were taken from the same population, and there
was no evidence that the main potential confounders had been
identified and accounted for. In all three studies, the nature of the
intervention meant blinding of clinicians involved in the delivery
of cough augmentation techniques was not feasible.
Potential biases in the review process
We believe the potential for bias in our review process is low. We
adhered to the procedures outlined by Cochrane (Higgins 2011),
as described in our review protocol (Rose 2015), including inde-
pendent screening for trial inclusion, data extraction, and assess-
ment of risk of bias by two review authors. We have made some
small modifications to the review from the original protocol (See
Differences between protocol and review), but we do not believe
these modifications introduced bias into the review process. We
made no assumptions about intensity of treatment that may in-
fluence findings, and made no decisions about analyses or investi-
gation of heterogeneity after seeing the data. We believe we have
identified all relevant studies through the use of a comprehen-
sive search strategy, developed in consultation with a senior In-
formation Specialist and peer-reviewed according to the PRESS
guidelines (McGowan 2010), in combination with a review of
trial databases, conference abstracts, and reference lists of relevant
literature, as well as contact with experts.
Agreements and disagreements with other
studies or reviews
This is the first published systematic review of studies comparing
cough augmentation techniques with usual care without cough
augmentation for extubation andweaning of critically-ill people. A
previous systematic review ofMI-E for people with neuromuscular
disease and not experiencing critical illness reported no serious
adverse events attributed toMI-E in the five studies that met their
inclusion criteria, but the authors noted that it was unclear if
adverse events were systematically investigated (Morrow 2013).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We were unable to find enough evidence to determine the effects
of cough augmentation techniques on extubation and weaning
success, ventilation and weaning duration, rates of tracheostomy
and tracheostomy decannulation, length of stay, and mortality for
critically-ill, mechanically-ventilated people. Very low-quality ev-
idence suggests cough augmentation techniques might improve
extubation success and decrease the duration of mechanical ven-
tilation while not increasing harm.
Implications for research
Due to the overall rating of very low-quality evidence arising from
the small number of trials with few participants and unclear risk
of bias, further studies of cough augmentation techniques in the
critically ill are warranted. Studies are required to determine which
type of critically-ill people may benefit or be at risk of harm from
cough augmentation techniques. Adequately-powered, multicen-
tre randomized controlled trials are needed not only comparing
cough augmentation techniques to weaning and extubation prac-
tices that do not include cough augmentation techniques, but also
head-to-head comparisons of the techniques themselves, and the
intensity of the intervention. Such trials should incorporate mea-
surement of peak cough flow before and after delivery of the inter-
vention. Studies are also needed to evaluate the most efficacious
pressures to generate cough and facilitate secretion expectoration
in the critically ill. Outcomes such as weaning, extubation success
andmechanical ventilation duration are confounded by other unit
practices such as the use of weaning protocols and other weaning
tools, pain and sedation management, as well as the structure and
organization of the ICU. Future trials should consider whether
these co-interventions should be protocolized within the trial de-
sign, or at least ensure that a detailed description of usual care is
documented.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Crowe 2006
Methods Single-centre (Canada; mixed medical-surgical-trauma ICU) randomized controlled
trial; 22-month period from January 2001
Participants 20 (10 intervention and 10 control) intubated adults (18 years and over) with at least
unilateral lobar atelectasis or bilateral areas of significant atelectasis as determined by
chest radiography Atelectasis was present for 72 hours or less
Excluded patients with: bullous emphysema; recent pneumothorax; cardiac or neurologic
instability; acute respiratory distress syndrome or acute lung injury; abdominal trauma
or recent abdominal surgery; pericardial tubes; unstable spinal or pelvic fractures; inferior
vena cava filters; PEEP ≥ 7.5 cm H2O; and patients likely to be extubated within less
than 12 hours
Interventions Intervention: Breath stacking using a resuscitation bag equipped with a one-way valve to
manually inflate the lung, in a step-like manner in 3 increments, to maximal insufflation
capacity with the objective of re-inflating atelectatic lung tissue. The breath-stacking
protocol immediately followed conventional physiotherapy, with the participant in a
side-lying position and the affected lung uppermost. Participants were oxygenated for 3
minutes on 100% FiO2 via the ventilator. 3 stacked breaths were given with bag squeezes
without air escape (using one-way valve) to maximal pressure of 40 cm H2O with a 10-
second hold at maximal pressure, followed by an abdominal thrust or chest squeeze
The procedure was repeated twice more (for a total of 3 cycles). Participants were suc-
tioned as required. The participant was allowed to rest on the ventilator for 3 - 5 min-
utes to allow vital signs to return to baseline. The procedure (3 stacked breaths, assisted
cough, suctioning and rest on ventilator) was repeated 3 times (for a total of 4 cycles
or 12 stacked breaths). Twice-daily treatment was continued until the participant was
extubated, to a maximum of 72 hours or 6 treatment sessions
Control: conventional physiotherapy (manual percussions and vibrations) twice daily for
periods of 15 to 20 minutes with the most affected side uppermost. Chest physiotherapy
was followed by 30 seconds of oxygenation and secretion removal via suctioning, without
saline installation
Outcomes Atelectasis quantified on routine daily chest radiograph by a blinded radiologist using
an adapted version of an atelectasis score used in a previous study by Joyce 1995
Oxygenation measured continuously, using a pulse oximeter, and recorded prior to treat-
ment, immediately following treatment, and 30 minutes after the procedure
Sputum volume collected in a 40 cc container with the volume visually estimated and
recorded at the end of the procedure
Notes Unable to locate in Pubmed for PMID
Funded by a grant from theCanadian PhysiotherapyCardio-respiratory Society, a branch
of the Canadian Lung Association
No declarations of conflicts of interest
Risk of bias Risk of bias
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Crowe 2006 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomly assigned using
a computer-generated random number ta-
ble
Allocation concealment (selection bias) Low risk Used a system of opaque sealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Participants and physiotherapist providing
the study treatments and researchers could
not be blinded, but it is unclear whether
this produced performance bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Primary outcome assessment (atelectasis)
was done by a blinded radiologist. There is
no evidence that the other study outcomes
were assessed in a blinded manner. Out-
comes not likely to be influenced by lack
of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent incomplete outcome data
Selective reporting (reporting bias) Low risk No protocol available, but no evidence of
selective outcome reporting
Other bias Unclear risk The study was forced to stop early, reaching
only half of the target sample size due to
failure to recruit participants
Gonçalves 2012
Methods Single-centre (Portugal, mixed medical-surgical-trauma ICU) randomized controlled
trial; between 2007 and 2009
Participants 75 (35 intervention; 40 control) adults (18 years and older) receiving mechanical ven-
tilation for more than 48 hours for acute hypoxaemic and/or hypercapnic respiratory
failure. To be eligible for the study, participants had to demonstrate readiness for discon-
tinuation of mechanical ventilation by successfully tolerating a spontaneous breathing
trial. People were excluded if demonstrating persistent weaning failure (failed 3+ spon-
taneous breathing trials in 1 week), required a tracheostomy, were haemodynamically or
neurologically unstable (unable to respond to direct simple orders), lack of co-operation,
experienced facial or cranial trauma, or active upper gastrointestinal bleeding or had a
confirmed diagnosis of neuromuscular disease
Interventions Intervention: After passing the spontaneous breathing trial and study randomization
and before extubation, participants received an MI-E treatment (3 sessions) using the
Cough Assist (Philips Respironics, Carlsbad, CA, USA) through the endotracheal tube
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Gonçalves 2012 (Continued)
with pressures set at 40 cm H2O for insufflation and -40 cm H2O for exsufflation. An
insufflation/exsufflation time ratio of 3:2 seconds and a pause of 3 seconds between each
cycle were used. 8 cycles were applied in every session with an abdominal thrust timed to
the exsufflation cycle.In addition to standard medical therapy, in the first 48 hours after
extubation, each participant received 3 daily MI-E treatments via a lightweight, elastic
oronasal mask. Treatments (3 sessions each) were divided between morning, afternoon,
and night. NoMI-E treatments were performed after the 48-hour study period. All MI-
E treatments were administered by a trained respiratory therapist, ICU physician, or
nurse. Other post-extubation management was the same as that for the control group
Control: Participants received postextubation standard medical therapy, including sup-
plemental oxygen (as needed), respiratory chest physiotherapy, bronchodilators, antibi-
otics, and other therapies as directed by the attending physician. Criteria for NIV in-
cluded: respiratory rate > 35 beats/min; SpO2 < 90%; 20% variation of heart rate or
blood pressure; dyspnoea with respiratory distress; PaO2 < 60 mm Hg; PaCO2 > 45
mmHg; pH < 7.35. NIV failure was declared when the criteria for its application were
not resolved or the person demonstrated NIV intolerance in the first 2 hours of use.
Noninvasive ventilation was provided via an ICU ventilator with noninvasive mode or
via a portable pressure-cycled ventilator through an oronasal mask as the first choice.
Other interfaces, such as nasal, total face, helmet, and mouthpieces were used if the
participant did not tolerate the oronasal mask. The fraction of inspired oxygen and the
positive end-expiratory pressure were titrated to maintain the arterial oxygen saturation
above 90% (or PaO2 > 60 mmHg). Ventilator settings were subsequently adjusted as
needed for the person’s comfort. The decision to discontinue noninvasive ventilation
was left to the attending physician
The decision to reintubate was that of the attending physician, who recorded the single
most relevant reason for reintubation
Outcomes Primary: reintubation rate defined as no need for reintubation within the first 48 hrs of
extubation
Secondary outcomes
Total ICU length of stay from admission to discharge
Postextubation ICU length of stay (time from extubation to ICU discharge)
NIV failure rate (not defined)
Notes Unclear if or who funded the study
Two authors received fees for lecturing and for attending professional meetings from
Philips Respironics, Inc., who have an interest in the subject of the manuscript
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A “computer-generated table” was used for
random allocation
Allocation concealment (selection bias) Low risk The randomization table and allocation se-
quence were concealed both from the pri-
mary investigator and from all medical, res-
piratory therapy, and nursing staff of the
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Gonçalves 2012 (Continued)
ICU
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No blinding of clinical staff, researcher
staff. or participants possible due to the na-
ture of the intervention, but it is unclear
whether this produced performance bias,
particularly as reintubation was at the dis-
cretion of the attending physician who was
not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not specified in the paper whether out-
come assessors were blinded, but unlikely
to bias assessment of objective outcomes
such as reintubation
Incomplete outcome data (attrition bias)
All outcomes
Low risk No evidence that there were missing data.
No attrition noted
Selective reporting (reporting bias) Unclear risk Outcomes match the registered protocol,
but this was registered after completion of
trial recruitment
Other bias Unclear risk Two of the study authors declared receiving
funds for lecturing and attending profes-
sional meetings from Philips Respironics,
the manufacturer of the Cough Assist De-
vice used in this study, although the man-
ufacturer did not provide funding or sup-
port for this trial
Niranjan 1998
Methods Single-centre (USA, paediatric ICU) case-control study; study period unclear, although
historical controls were taken from the preceding 10 years
Participants 17 children (10 cases and 7 controls) with neuromuscular disease admitted for respiratory
distress
None of the cases was unable to sustain > 2 minutes of ventilator-free breathing
Children were excluded if, whether intubated or not, they could survive without using
ventilatory support
An additional participant was excluded for hypotension with cardiac failure secondary
to terminal cardiomyopathy
Historical controls comprised children with neuromuscular disease admitted to the par-
ticipating unit in the preceding 10 years who failed conventional management before the
inception of the extubation protocol, and received invasive ventilation via a tracheostomy
Interventions Intervention: Assisted coughing was initiated manually or mechanically if the SaO2
was < 95%. Participants were encouraged to first air-stack to maximum lung volumes
before receiving manual cough assistance. Manually-assisted coughing was provided by
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Niranjan 1998 (Continued)
an assistant compressing the upper abdomen in synchrony with the child’s own cough.
Mechanical insufflation-exsufflation was provided via the endotracheal tube by the In-
exsufflator using inspiratory pressures of +35 to +45 cm H2O and expiratory pressures
of -35 to -45 cm H2O. Cough flows were increased further by manually compressing
the upper abdomen concomitantly with the forced exsufflation. Any episodic decreases
in SaO2 < 95% were treated with assisted coughing until mucus was extruded and SaO2
levels returned to baseline
Portable volume ventilators (PLV-100, Respironics) with assist-control mod and tidal
volumes of 800 to 1500 mL and without positive end-expiratory pressure (PEEP). In-
tubated children were managed conventionally with respect to ventilation, analgesia,
sedation, and nutrition (nasogastric feeds). No weaning attempts were made. Extubation
was attempted only when no supplemental oxygen was required to maintain an SaO2
of > 94% and when any chest radiograph abnormalities improved. All participants were
extubated to continuous noninvasive intermittent positive pressure ventilation. After
extubation, assisted peak cough flow was measured
Control: The historical controls failed conventional management before the inception
of our protocol and received a tracheostomy
Outcomes Level of respiratory support at PICU discharge (nil; nighttime only; > 16 hours of
support)
Need for reintubation
Upper respiratory infection after discharge (acute upper respiratory infections that ne-
cessitated reintroduction of the protocol)
Hospital readmission
Mortality after discharge
Tracheostomy after discharge
Length of stay
Notes Unclear if or who funded the study
No mention of author conflicts of interest
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Non-randomized study, therefore not as-
sessed
Allocation concealment (selection bias) Unclear risk Non-randomized study, therefore not as-
sessed
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Non-randomized study, therefore not as-
sessed
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Non-randomized study, therefore not as-
sessed
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Niranjan 1998 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Non-randomized study, therefore not as-
sessed
Selective reporting (reporting bias) Unclear risk Non-randomized study, therefore not as-
sessed
Other bias Unclear risk Non-randomized study, therefore not as-
sessed
Cm H2O: centimetres of water; FiO2: Fraction of inspired oxygen; mm Hg: millimetres of mercury; ICU: intensive care unit; MI-E:
mechanical insufflation-exsufflation; NIV: non-invasive ventilation; PaO2: partial pressure (arterial) of oxygen; PEEP: positive end
expiratory pressure; pH: acid-basemeasured on logarithmic scale; PICU: paediatric intensive care unit; PMID: PubMed identification
number; SpO2: oxygen saturation (peripheral)
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Avena 2008 Non-randomized study without a control group
Bach 1996 Non-randomized study without a control group
Bach 2010 Non-randomized study without a control group
Bach 2015 Non-randomized study without a control group
Beuret 2014 Intervention did not comprise a cough augmentation technique
Chen 2014 Participants were not using invasive ventilatory support at study entry and therefore cough augmentation
techniques were used to prevent intubation as opposed facilitating weaning and preventing reintubation
Duff 2007 Intervention did not comprise a cough augmentation technique
Jeong 2015 Patients were excluded if requiring invasive ventilatory support
Ntoumenopulos 2014 Non-randomized study without a control group
Porto 2014 Cross-over randomized controlled trial. This design means it is impossible to determine which intervention
impacts on fixed clinical outcomes such as extubation success
Torres-Castro 2014 Patients were excluded if requiring invasive ventilatory support
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(Continued)
Toussaint 2003 Cross-over randomized controlled trial. This design means it is impossible to determine which intervention
impacts on fixed clinical outcomes such as extubation success
Velasco Arnaiz 2011 Non-randomized study without a control group
Vianello 2005 Participants were not using invasive ventilatory support at study entry and therefore cough augmentation
techniques were used to prevent intubation as opposed facilitating weaning and preventing reintubation
Vianello 2011 Control arm also included a cough augmentation technique (manually-assisted cough)
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Table of secondary outcomes
Cough augmentation No cough augmentation
Study N mean (SD) N mean (SD) mean difference 95% CIs
Duration of mechanical ventilation (days) Duration of mechanical
(days)
Gonçalves 2012 35 11.7 (3.5) 40 17.8 (6.4) -6.1 -8.4 to -3.8
ICU length of stay (days)1 ICU length of stay
Gonçalves 2012 35 16.9 (11.1) 40 19.3 (8.1) -2.4 -6.9 to 2.01
Niranjan 1998 10 47.6 (7.3) 7 51.1 (7.8) -3.5 -10.8 to 3.8
1The ICU length of stay for cases reported in Niranjan 1998 includes the four cases that were not intubated at the start of the study.
Table 2. Adverse effects
Cough augmentation No cough augmentation
Study Events Total Events Total RR 95% CIs
Haemodynamic compromise Haemodynamic compromise
Gonçalves 2012 1 35 0 40 3.4 0.1 to 81.3
Crowe 2006 1 10 0 10 3.0 0.1 to 65.9
Secretion encumbrance resulting in severe hypoxaemia requiring reintubation Secretion encumbrance
ing reintubation
Gonçalves 2012 2 35 9 40 0.25 0.1 to 1.1
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We added randomized cross-over studies as an exclusion criterion, as this design does not allow determination of the efficacy of the
intervention on clinical outcomes such as weaning success.
We clarified that included non-randomized studies were those with a non-exposed control group.
We added duration of weaning, length of stay, tracheostomy, and tracheostomy decannulation to the outcomes listed in the Outcomes
section to align with our a priori set objectives.
As we had anticipated that no eligible trials would be blinded to the use of cough augmentation techniques, we added in the review that
non-blinding of personnel and participants would not necessarily be rated as high risk of bias when considering objective outcomes.
We revised the review to state that high risk of bias was defined as one or more domains (as opposed to two) scored as high risk, as this
reflects the guidance in the Cochrane Handbook for Systematic Reviews of Interventions . We also clarified that unclear risk of bias also
means that no domains are scored as high risk of bias.
Due to the small number of studies meeting our inclusion criteria, we could not synthesize data and conduct a meta-analysis; assess
statistical heterogeneity; perform subgroup and sensitivity analyses; and construct funnel plots to assess reporting bias, as planned in
our protocol (Rose 2015).
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Airway Extubation [∗methods]; Cohort Studies; Cough [∗physiopathology]; Critical Illness; Insufflation [methods]; Intensive Care
Units; Length of Stay; Randomized Controlled Trials as Topic; Ventilator Weaning [∗methods]
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Adult; Humans; Infant
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